Le Lézard
Classified in: Health, Covid-19 virus
Subject: Contests/Awards

CHAIR 2021 Leadership Award Winner ? Dr. Victor Leung


TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Since 2014, CHAIR, the Coalition for Community and Healthcare Acquired Infection Reduction, has recognized the leadership of an individual or organization passionate about reducing acquired infections through engineered infection prevention technologies.

CHAIR is pleased to select Dr. Victor Leung as the 2021 CHAIR Leadership Award recipient. Dr. Leung is the Medical Director of Infection Prevention and Control and the Physician Lead of Antimicrobial Stewardship at Providence Health Care (PHC) in Vancouver, BC.

More information on Dr. Leung can be found here: https://www.providencelaboratory.com/staff_leung.php

"CHAIR acknowledges Dr. Leung's leadership in recognizing the airborne nature of transmission of SARS-CoV-2 and his advocacy, education, and implementation of engineered infection prevention mitigation strategies to reduce airborne hospital-associated infections," said Barry Hunt, cofounder of CHAIR.

"The COVID-19 pandemic has emphasized the importance of engineered solutions in Infection Prevention and Control (IPAC). I strongly believe that if we are to make advances in IPAC, we need to work with engineers to identify and help implement tested and impactful engineered solutions to mitigate the risk of transmission.  COVID-19 has made it abundantly clear that we need to pay attention to cleaning the air," said Dr. Leung upon receiving his award.

Some of the highlights that led to this decision include:

"This is the eighth year this distinguished award has been presented and, without question, this year's award is being given to the worthiest person who has accomplished so much in his career to keep both the general public and the most vulnerable healthcare patients safe," said Richard Dixon, cofounder of CHAIR Canada.

For 2022 CHAIR has a new Vision: "Safe Spaces, free from pathogens," and a new Mission: "Inspire and guide research-based engineered solutions."  

"Dr. Leung's work during the pandemic truly aligns him with our vision and mission," said Steve Reinecke, Executive Director of CHAIR. "We thank Dr. Leung for his contribution to reducing infections and look forward to following him in his future accomplishments."

About CHAIR.

CHAIR is a coalition of members working on promoting and introducing engineered solutions to reduce Community and Healthcare Infections. CHAIR was formed in 2014 with the original goal of supporting the creation of a safe healthcare environment for patients, staff, and visitors by achieving an 80% reduction in healthcare-acquired infections (HAIs) by 2024. The coalition has recently revised its vision and mission and developed a new strategic roadmap (2022-2024). It seeks to have a more significant impact on reducing community and healthcare-acquired infections by building awareness and facilitating the application of engineered solutions (air, water, and surface).

For further information:
Steve Reinecke
[email protected] 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/90f02aa0-e8fb-4ba7-bd79-51ed4b44ccc6



These press releases may also interest you

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 19:56
Rare Cannabinoid Company is proud to announce the launch of its new,...

at 18:58
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...



News published on and distributed by: